Elderly Patients
Resource Center
Featured
06/23/2026
Anthony Calabro, MA
The FDA approved ensitrelvir (Xocova) for post-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older following contact with an individual with COVID-19.
06/23/2026
06/22/2026
Rajesh R. Tampi, MD, MS, FAPA
In this video interview, Rajesh R. Tampi, MD, discusses how a new FDA-approved medication may fit into the treatment landscape for agitation associated with Alzheimer disease.
06/22/2026
05/30/2026
Kalyani N. Ballur, MD; Oluwaferanmi T. Dada, BS; Evan Maroun, MS; Kevin Pierre, MD; Troy Storey, MD; Diego A. L. Garcia, MD
A 67-year-old man, monitored since October 2022 for an incidental left proximal femoral lesion, arrived as a transfer from an outside hospital where he presented with an inability to walk after feeling a...
05/30/2026
Interactive Features
12/18/2025
Anthony Calabro, MA
According to the authors of a recent review on lower back pain (LBP), obtaining a comprehensive medical history is the most critical tool for identifying risk factors for serious disease in a patient with...
12/18/2025
07/28/2025
Kate Young
A recent study review examined the role of music therapy on quality of life in geriatric populations. Do you know how music therapy can help patients with Alzheimer disease? Take the quiz to test your...
07/28/2025
07/28/2025
A review found that loneliness and social isolation can affect behaviors such as medication adherence and health care engagement in adults aged 50 years and older living with HIV.
07/28/2025
03/25/2025
Anthony Calabro, MA
How current is your knowledge on endometrial cancer? Take this quiz series and see if you pass the test!
03/25/2025
11/11/2023
Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...
11/11/2023
Clinical Insights
06/22/2026
Rajesh R. Tampi, MD, MS, FAPA
In this video interview, Rajesh R. Tampi, MD, discusses how a new FDA-approved medication may fit into the treatment landscape for agitation associated with Alzheimer disease.
06/22/2026
09/11/2025
Kasia Rothenberg, MD, PhD
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
09/11/2025
11/20/2024
Gautam Dantas, PhD
In this video, Gautam Dantas, PhD, discusses the results of his study, which showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease. He also talks about whether...
11/20/2024
11/08/2024
In this video, Aldis H. Petriceks, BA, discusses his team's study, which set out to determine the optimal timepoints for assessing orthostatic hypotension in older adults, as well as the association between...
11/08/2024
03/18/2024
The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
03/18/2024
